Mpox (monkeypox) vaccine Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox)vaccine Intradermal JYNNEOS Mpox (monkeypox) vaccine Subcutaneous JYNNEOS mpox (monkeypox) vaccine AusVaxSafety is conducting active vaccine safety surveillance of mpox (monkeypox) vaccines in use in Australia to ensure their ongoing safety. Data on this page will be updated fortnightly. Latest fortnightly mpox vaccine safety data Click on the tiles below to view subcutaneous and intradermal mpox vaccine safety data. Intradermal JYNNEOS mpox (monkeypox) vaccine View the latest intradermal JYNNEOS mpox vaccine safety data here Subcutaneous JYNNEOS mpox (monkeypox) vaccine View the latest subcutaneous JYNNEOS mpox vaccine safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox)vaccine Intradermal JYNNEOS Mpox (monkeypox) vaccine Subcutaneous JYNNEOS mpox (monkeypox) vaccine News & events All news & events 31 January 2023 | News Short-term adverse event profile of COVID-19 mRNA vaccines in Aussie kids: reassuring data from AusVaxSafety 22 December 2022 | News How common are severe side effects from COVID vaccines? And how are they detected? 12 December 2022 | News AusVaxSafety wins Research Australia Data Innovation Award 27 October 2022 | News JYNNEOS mpox (monkeypox) vaccination – dose 2 better tolerated than dose 1